Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19.82%18.11B | 8.67%68.06B | 6.98%15.12B | 11.40%62.63B | 11.87%18.79B | 5.88%14.13B | 23.53%15.59B | 4.92%14.13B | 9.77%56.22B | -0.86%16.79B |
| Cost of revenue | 14.11%10.96B | 4.34%41.91B | 3.99%9.6B | 11.16%40.16B | 11.00%12.21B | 13.38%8.79B | 20.14%9.92B | 1.34%9.23B | 4.59%36.13B | -5.48%11B |
| Gross profit | 29.78%7.16B | 16.41%26.15B | 12.63%5.51B | 11.83%22.47B | 13.55%6.57B | -4.57%5.33B | 29.96%5.67B | 12.43%4.9B | 20.50%20.09B | 9.29%5.79B |
| Operating expense | 22.18%4.15B | 17.58%15.9B | 8.52%3.4B | 5.47%13.52B | 9.22%3.92B | 1.88%3.14B | 6.63%3.33B | 3.47%3.13B | 14.89%12.82B | 5.81%3.59B |
| Staff costs | ---- | 5.34%6.14B | ---- | 7.95%5.83B | ---- | ---- | ---- | ---- | 7.87%5.4B | ---- |
| Selling and administrative expenses | ---- | 27.05%1.48B | ---- | -37.10%1.17B | ---- | ---- | ---- | ---- | 26.07%1.86B | ---- |
| -Selling and marketing expense | ---- | 12.46%325M | ---- | 22.98%289M | ---- | ---- | ---- | ---- | 4.91%235M | ---- |
| -General and administrative expense | ---- | 31.85%1.16B | ---- | -45.81%879M | ---- | ---- | ---- | ---- | 29.86%1.62B | ---- |
| Depreciation and amortization | ---- | 9.68%408M | ---- | 15.53%372M | ---- | ---- | ---- | ---- | 10.27%322M | ---- |
| -Depreciation | ---- | 9.68%408M | ---- | 15.53%372M | ---- | ---- | ---- | ---- | 10.27%322M | ---- |
| Rent and land expenses | ---- | 7.20%253M | ---- | 15.12%236M | ---- | ---- | ---- | ---- | 15.17%205M | ---- |
| Other operating expenses | ---- | 28.68%7.62B | ---- | 17.47%5.92B | ---- | ---- | ---- | ---- | 19.64%5.04B | ---- |
| Operating profit | 42.01%3B | 14.64%10.25B | 19.91%2.11B | 23.06%8.94B | 20.61%2.65B | -12.50%2.19B | 88.71%2.34B | 32.86%1.76B | 31.86%7.27B | 15.50%2.2B |
| Net non-operating interest income (expenses) | -31.25%88M | 1.03%392M | 42.22%128M | 52.16%388M | 76.67%106M | 53.13%98M | 42.42%94M | 38.46%90M | -0.39%255M | -15.49%60M |
| Non-operating interest income | -17.61%117M | 20.51%523M | 43.43%142M | 62.55%434M | 77.94%121M | 69.70%112M | 50.00%102M | 52.31%99M | 0.38%267M | -6.85%68M |
| Non-operating interest expense | 107.14%29M | 184.78%131M | 55.56%14M | 283.33%46M | 87.50%15M | 600.00%14M | 300.00%8M | --9M | 20.00%12M | 300.00%8M |
| Net investment income | -143.91%-692M | -103.35%-96M | -11.01%1.58B | 119.95%2.87B | 2,930.00%1.13B | 28.24%-643M | -29.53%606M | 28.43%1.77B | -7.92%1.3B | -104.73%-40M |
| Gain(Loss) on financial instruments designated as cash flow hedges | -62.24%-159M | -60M | -98M | 110M | 0 | 0 | ||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 74.45%-35M | -369.23%-35M | 120.27%15M | 0.00%-6M | 87.14%-9M | -813.33%-137M | 186.67%13M | ||
| Income from associates and other participating interests | 0 | -143.48%-60M | -387.50%-23M | 138M | 53M | -5M | 82M | 8M | 0 | 0 |
| Special income (charges) | -344M | 460.00%1.62B | -423.26%-450M | -333.16%-450M | 0 | 0 | 0 | -8,500.00%-86M | 19,400.00%193M | |
| Less:Restructuring and mergern&acquisition | ---- | ---1.72B | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | ---- | 16.22%-186M | ---- | -247.02%-222M | ---- | ---- | ---- | ---- | 15,000.00%151M | ---128M |
| Less:Write off | --344M | -57.29%287M | ---- | 1,133.85%672M | ---- | ---- | ---- | ---- | ---65M | ---- |
| Other non-operating income (expenses) | -46.97%35M | -59.06%165M | -58.23%66M | 31.27%403M | -3.85%125M | 844.44%67M | -36.14%53M | 53.40%158M | 49.76%307M | 490.91%130M |
| Income before tax | -45.09%2.09B | -0.34%12.11B | 0.53%3.8B | 36.49%12.15B | 44.68%3.69B | -5.01%1.52B | 42.32%3.17B | 49.27%3.78B | 20.85%8.9B | -9.61%2.55B |
| Income tax | -39.50%726M | -11.24%3.18B | 11.21%1.2B | 44.83%3.59B | 61.05%1.14B | 59.81%497M | 40.58%873M | 28.76%1.08B | -1.00%2.48B | -42.18%706M |
| Net income | -47.67%1.36B | 4.24%8.93B | -3.74%2.6B | 33.28%8.57B | 38.36%2.55B | -20.64%1.02B | 42.99%2.3B | 59.41%2.7B | 32.05%6.43B | 15.26%1.84B |
| Net income continuous operations | -47.67%1.36B | 4.23%8.93B | -3.74%2.6B | 33.28%8.57B | 38.42%2.55B | -20.70%1.02B | 42.99%2.3B | 59.41%2.7B | 32.07%6.43B | 15.26%1.84B |
| Noncontrolling interests | 55.42%129M | -47.48%146M | 2.47%83M | 69.51%278M | 2,100.00%22M | -32.23%82M | 365.00%93M | 268.18%81M | 234.69%164M | 150.00%1M |
| Net income attributable to the company | -51.11%1.23B | 5.97%8.78B | -3.89%2.52B | 32.35%8.29B | 37.32%2.53B | -19.35%938M | 38.84%2.2B | 56.70%2.62B | 30.00%6.26B | 14.99%1.84B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -51.11%1.23B | 5.97%8.78B | -3.89%2.52B | 32.35%8.29B | 37.32%2.53B | -19.35%938M | 38.84%2.2B | 56.70%2.62B | 30.00%6.26B | 14.99%1.84B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -50.16%25.51 | 6.25%179.36 | -4.31%51.185 | 32.94%168.81 | 37.19%51.44 | -19.21%19.055 | 39.49%44.825 | 58.42%53.49 | 31.93%126.98 | 17.12%37.495 |
| Diluted earnings per share | -50.16%25.51 | 6.25%179.36 | -4.31%51.185 | 32.94%168.81 | 36.78%51.2848 | -19.21%19.055 | 39.48%44.8229 | 58.42%53.49 | 31.93%126.98 | 17.12%37.495 |
| Dividend per share | 0 | 13.64%25 | 0 | 10.00%22 | 9.09%12 | 0 | 11.11%10 | 0 | 11.11%20 | 4.76%11 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |